Company Monitoring Page for Gilead

latest headlines for company on cafepharma

A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
Tags:
drug approvals, earnings, Amylin, InterMune, Human Genome Sciences, GSK, Bristol-Myers Squibb, Questcor, BiogenIdec, Alexion, Regeneron, Eli Lilly, Amarin, Horizon Pharma, Celgene, Amgen, Gilead, Alkermes, United Therapeutics, Roche, Sanofi, Merck, AstraZeneca, Salix, Progenics Pharmaceuticals
FDA Approves New Gilead Medication for HIV Prevention Study
WSJ Online
Thu, 07/19/12 - 07:41 am
Tags:
FDA, HIV, Gilead, Truvada
Gilead Faces Big Issues With AIDS Vaccine
Seeking Alpha
Tue, 07/17/12 - 12:22 pm
Tags:
Truvada, HIV, AIDS, Gilead, vaccines
Gilead Wins U.S. Approval For First HIV Prevention Pill
Bloomberg
Mon, 07/16/12 - 01:41 pm
Tags:
Gilead, HIV, AIDS, Truvada
Can These 3 Companies Take Down Gilead?
Motley Fool
Thu, 07/12/12 - 11:27 am
Tags:
Gilead, HIV, ViiV Healthcare, Shionogi, Merck, Bristol-Myers Squibb
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wed, 07/11/12 - 10:19 am
Tags:
GSK, HIV, AIDS, Shionogi, Gilead, Atripla, Dolutegravir
3 Things to Watch With Gilead Sciences
Motley Fool
Tue, 07/10/12 - 11:13 am
Tags:
Gilead, patents, hepatitis C
Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications
Forbes
Fri, 06/29/12 - 09:25 am
Tags:
hepatitis C, Bristol-Myers Squibb, Gilead, NS5A Inhibitors, daclatasvir
Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat
Yahoo
Thu, 06/28/12 - 06:13 pm
Tags:
FDA, Gilead, cobicistat
Bristol Hep C Trial Change Has Big Implications
Pharmalot
Wed, 06/20/12 - 12:31 pm
Tags:
hepatitis C, Bristol-Myers Squibb, clinical trials, Gilead, NS5A Inhibitors, declatasvir
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Fri, 06/1/12 - 12:30 pm
Tags:
Bristol-Myers Squibb, Gilead, hepatitis C, Lamberto Andreotti, daclatasvir, GS-7977
High Profitability and Low Valuation for Gilead
Motley Fool
Mon, 05/28/12 - 11:19 am
Tags:
Gilead
Gilead’s Pill Wins U.S. Panel Backing to Prevent HIV
Bloomberg
Fri, 05/11/12 - 11:18 am
Tags:
Gilead, HIV, Truvada
1 Biotech With 2 Binary Events in 2 Days
Motley Fool
Thu, 05/10/12 - 11:07 am
Tags:
Gilead, HIV, Truvada, Quad
Gilead’s Quad Pill Raises Kidney Questions, FDA Says
Bloomberg
Wed, 05/9/12 - 10:54 am
Tags:
Quad, FDA, HIV, Gilead
Gilead’s Truvada Pill Is Safe for HIV Prevention, FDA Says
Bloomberg
Tue, 05/8/12 - 10:57 am
Tags:
Gilead, Truvada, HIV, FDA
Truvada up for FDA debate as HIV preventive
Fierce Pharma
Mon, 05/7/12 - 12:17 pm
Tags:
HIV, Truvada, FDA, Gilead
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Tags:
Roche, Merck, dalcetrapib, Abbott Laboratories, Bristol-Myers Squibb, Gilead, Eli Lilly, Pfizer, Sanofi, Illumina
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wed, 05/2/12 - 11:12 am
Tags:
drug approvals, FDA, Regeneron, ONYX Pharmaceuticals, Pfizer, Celgene, Arena Pharmaceuticals, Alexa, Gilead, Merck, Ironwood, Vivus, Navidea Biopharmaceuticals, NPS Pharmaceuticals, Raptor Pharmaceuticals, Santarus, Biogen Idec
Higher Costs Hurt Gilead
Yahoo/Zacks
Fri, 04/27/12 - 11:09 am
Tags:
Gilead, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.